This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
Wall Street continued its winning streak on Friday as high-level delegations of the United States and China are set resume trade talks next week. Moreover, Mexico expressed its willingness to resolve bilateral trade issues with the United States by the middle of next week. Optimistic views from several fronts on global trade-related concerns have restored investor’s confidence in risky assets like equities.
TXN AMT SPG
MEXICO CITY, Aug 16 (Reuters) - Credit ratings agency Fitch on Thursday placed TV Azteca on “negative watch,” warning of the risks of the Mexican broadcaster’s legal dispute with American Tower Corp as the companies attempt to reach a settlement.
2018-08-14 zacks - 1
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features updated research reports on 12 major stocks, including UnitedHealth (UNH), PepsiCo (PEP) and Amgen (AMGN). These research reports have been hand-picked from roughly 70 reports published by our analyst team today.
FOX GD AMGN CQP LNG CVS CLH ABB 7018 PEP AMT CME ABLZF TXT UNH FOXA
Outfront Media (NYSE:OUT) plunged in Thursday trading following its second-quarter earnings report. The real estate investment trust (REIT) fell by almost 9.5% in Thursday trading as it missed earnings and revenue estimates. Nearly four and one-half years after it began trading, Outfront stock trades at over 32% below its original IPO price.
AMT GOOGL GOOG CCI OUT
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features updated research reports on 16 major stocks, including Mastercard (MA), AbbVie (ABBV) and Twenty-First Century Fox (FOXA). These research reports have been hand-picked from roughly 70 reports published by our analyst team today.
FOX GD ZTO MA BXP TCO CVS FTV 7018 ALXN AMT CME PPL ABBV FOXA ABBV
Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider either Outfront Media (OUT - Free Report) or American Tower (AMT - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
If the pricey stock market has you worried, one safe place to look at is telecommunications, especially the big carriers and the tower companies. One thing that never goes out-of-favor, even when times get tough, is people needing their phone, and most people these days operate on wireless smartphones.
DB AMT CCI
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features updated research reports on 16 major stocks, including Merck (MRK), CVS Health (CVS) and CME Group (CME). These research reports have been hand-picked from roughly 70 reports published by our analyst team today.
PSA.A CVS CME AMT PSAXZ GD NYTAB NEXGY PSA XEL 7018
Wireless communication tower operator American Tower Corporation (AMT - Free Report) recently purchased telecom assets from Brazilian state-run utility company, Cia Energetica de Minas Gerais SA, or Cemig, Reuters reported.
GJV AMT NWS NWSA CCI HST SBAC
MEXICO CITY (Reuters) - Credit ratings agency Fitch voiced concerns on Thursday that TV Azteca’s legal battle with American Tower Corp was “not positive or favorable” for the Mexican broadcaster’s credit profile, two days after Reuters reported the lawsuit.
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features updated research reports on 16 major stocks, including Chevron (CVX), General Dynamics (GD) and Emerson Electric (EMR). These research reports have been hand-picked from roughly 70 reports published by our analyst team today.
BRK.A GD AVF AMT XOM CVX MET AIG 8685
2018-08-20 - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
2018-08-20 - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...
as of ET